For the treatment of Neuropsychiatric Symptoms in Parkinson’s Disease
Saved in:
| Main Authors: | Arnold Bakker, Ph.D., Gregory Pontone, M.D., Richard Mohs, Ph.D., Michela Gallagher, Ph.D. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Series: | Neurotherapeutics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924000941 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non‐carriers with mild cognitive impairment due to Alzheimer's disease
by: Arnold Bakker, et al.
Published: (2024-10-01) -
Neuropsychiatric symptoms revealing Morgagni-Stewart-Morel syndrome: About 2 cases
by: Mehdi El Azouzi, MD, et al.
Published: (2025-08-01) -
Purpose in Life in Parkinson’s Disease: Its Relationships with Well-Being, Psychological Distress and Motor Function
by: Francesca Vescovelli PhD, et al.
Published: (2024-12-01) -
The Effect of Sensory Reweighting on Postural Control and Cortical Activity in Parkinson's Disease: A Pilot Study
by: Maryam Sadeghi, MS, et al.
Published: (2024-12-01) -
Alleviating effect of intranasal zinc on symptoms of allergic rhinitis
by: Huadong Xu, PhD, et al.
Published: (2025-05-01)